Skip to main content
Premium Trial:

Request an Annual Quote

Sionex Raises $12.8M in Series B Financing

NEW YORK, Nov. 20 (GenomeWeb News) - Sionex, which is commercializing chemical sensor chips for biopharmaceutical and other applications, raised $12.8 million in a Series B round of funding, the company said today.


The funding was led by Morgenthaler Ventures, with additional funds from Rho Ventures and Navigator Technology Ventures, which are existing investors in the Waltham, Mass., company.


The company plans to use the capital to further develop and manufacture its products, and to expand  partnerships. In October, Sionex signed a deal with Varian to incorporate its microDMx technology into Varian's gas chromatography products. The company is also positioning its sensor technology as applicable to detection of chemical and biological agents for defense and homeland security applications, and to the biopharmaceutical, environmental, commercial, and diagnostic applications.


Sionex's microDMx technology is based on the technique of Field Asymetric Ion Mobility Spectrometry, or FAIMS, and its microfabrication in a MEMS format.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.